The peptides observed in both clinical groups were similar to those observed in the pooled CSF, but there were increased amounts of the three major NfL species in Alzheimer’s disease compared with controls (Fig. 3). This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.